VAERS reports by lot

Merck Pneumococcal lot R012632: VAERS reports

24 VAERS reports list lot R012632 as a Merck Pneumococcal vaccine, received between 2018-06-30 and 2020-03-23. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
24
Reports
4%
Marked serious
0
With a death outcome
10
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction4251%
General / Systemic (non-local)1113%
Allergic / Anaphylactic1012%
Musculoskeletal911%
Dermatological (non-injection-site)56%
Neurological45%
Cardiac / Cardiovascular11%
Respiratory11%

Where reports came from

U.S. state of the reporter, where given (top 12).

New York5
Florida3
Pennsylvania2
Georgia1
Missouri1
Maryland1
Connecticut1
Kansas1
Nebraska1
Virginia1
North Carolina1
California1

Reports by month received

2018-061
2018-091
2018-107
2018-116
2018-122
2019-011
2019-042
2019-082
2019-101
2020-031

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.